Uridine and PUFA Composition for Synaptic Membrane Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for pediatric neurological disorders and brain development are inadequate, and the factors influencing brain development and intelligence levels are not well understood.
Innovation Solution
Administering a composition comprising omega-3 fatty acids, omega-6 fatty acids, uridine, or their metabolic precursors to pregnant or nursing mothers to enhance brain development, intelligence, and synaptic membrane synthesis in neural cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapies are used for pediatric neurological disorders, then treatment is provided, but the therapies are inadequate and do not sufficiently enhance brain development or intelligence
Solution Approach 1:
The patent changes the biochemical parameters of brain cell function by administering specific compositions containing uridine and polyunsaturated fatty acids (PUFAs). These compounds alter the metabolic state of neural cells, enhancing phospholipid synthesis and synaptic membrane formation, thereby improving both therapeutic efficacy and brain development outcomes simultaneously.
Solution Approach 2:
The invention uses a composite nutritional composition combining multiple essential components: uridine (a pyrimidine nucleoside), omega-3 PUFAs (e.g., DHA), omega-6 PUFAs (e.g., arachidonic acid), and choline. This composite formulation works synergistically to enhance phospholipid synthesis, promote synaptic membrane formation, and improve cognitive function, resolving the contradiction between reliable therapy and enhanced brain development.
2Loss of information
If factors influencing brain development are not well understood, then research continues, but effective therapies cannot be developed
Solution Approach 1:
The patent identifies and utilizes key biochemical precursors (uridine and PUFAs) that are essential for phospholipid synthesis before neural development issues manifest. By administering these compounds preliminarily during critical periods of brain development, the therapy proactively enhances synaptic membrane formation and cognitive function, making therapy development more straightforward despite incomplete understanding of all brain development factors.
3Quantity of substance
If synaptic membrane synthesis is not enhanced, then brain cell function remains limited, but intelligence and cognitive function cannot be improved
Solution Approach 1:
The patent provides exogenous uridine and PUFA substrates that neural cells use to copy and expand their phospholipid pools for synthesizing new synaptic membranes. This substrate supplementation enables increased synthesis of phosphatidylcholine and other phospholipids, directly increasing synaptic membrane quantity and thereby improving cognitive function and intelligence.
Data Source
AI summary
This invention provides methods of enhancing brain development; increasing or enhancing intelligence; increasing or enhancing synthesis and levels of phospholipids, synapses, synaptic proteins, and synaptic membranes by a neural cell or brain cell, comprising contacting a subject or a pregnant or nursing mother thereof with a composition comprising an omega-3 fatty acid, an omega-6 fatty acid, and/or uridine, a metabolic precursor thereof, or a combination thereof.